Literature DB >> 6935760

Anticoagulant properties of heparin and heparin fractions.

E Holmer.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6935760     DOI： 10.1111/j.1600-0609.1980.tb02511.x

Source DB:  PubMed          Journal:  Scand J Haematol Suppl        ISSN： 0080-6722


× No keyword cloud information.
  4 in total

1.  Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).

Authors:  N Imanishi; Y Komuro; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.

Authors:  R A Steiner; K Keller; T Lüscher; W E Schreiner
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  [Use of low molecular-weight heparin in hemodialysis patients].

Authors:  J Schrader; J Rieger; H Müschen; W Stibbe; H Köstering; P Kramer; F Scheler
Journal:  Klin Wochenschr       Date:  1985-01-15

4.  Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III.

Authors:  C Mattsson; M Hoylaerts; E Holmer; T Uthne; D Collen
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.